Why Cell and Gene Therapies Cost So Much – And What Can Be Done
Is Business Broken?
Navigating Insurance Barriers for Gene Therapies
This chapter explores the complexities patients face when seeking insurance approval for costly cell and gene therapies. It highlights the tension between insurers' financial stewardship and urgent patient needs, revealing disparities in access based on insurance type and the historical context of medical advancements.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
